Subtype
Laryngeal Neoplasm
CI-CAN-00001063Explore in graph →
Non-malignant70 active trials2 evidence items
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00001063Explore in graph →
Clinical trials
309 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT05375266 | Immune Biomarker Study for Head and Neck Cancer(ImmunBio-KHT) | recruiting | — | 1,100 | University of Erlangen-Nürnberg Medical SchoolOTHER | 1 | May 17, 2023 | clinicaltrials |
| NCT05857202 | Oxidative Stress and Inflammation Biomarkers in Surgically Treated Patients With Laryngeal Cancer | unknown | — | 100 | Clinical Centre of SerbiaOTHER | 1 | May 12, 2023 |
| clinicaltrials |
| NCT05688488 | Clinical Study of Curcumin in Preventing Postoperative Adhesion of Bilateral Vocal Cords | recruiting | Phase 1 / Phase 2 | 100 | Eye & ENT Hospital of Fudan UniversityOTHER | 1 | May 6, 2023 | clinicaltrials |
| NCT02198131 | Pulsed Dye Laser in Treating Patients With Post Radiation Dysphonia | completed | N/A | 9 | Wake Forest University Health SciencesOTHER | 1 | Apr 26, 2023 | clinicaltrials |
| NCT05830240 | A Clinical Study on Oncolytic Virus Injection (R130 OV) for the Treatment of Relapsed/Refractory Head and Neck Cancer | unknown | Early Phase 1 | 9 | Shanghai Yunying Medical TechnologyINDUSTRY | 1 | Apr 26, 2023 | clinicaltrials |
| NCT04110249 | Photoacoustic Imaging for Measuring Tumors and Normal Tissue in Patients With Head and Neck Cancer | terminated | N/A | 14 | Roswell Park Cancer InstituteOTHER | 1 | Apr 10, 2023 | clinicaltrials |
| NCT01332279 | Everolimus, Erlotinib Hydrochloride, and Radiation Therapy in Treating Patients With Recurrent Head and Neck Cancer Previously Treated With Radiation Therapy | withdrawn | Phase 1 | 0 | Fox Chase Cancer CenterOTHER | 1 | Apr 4, 2023 | clinicaltrials |
| NCT02582008 | Bupropion Hydrochloride or Patient's Choice for Smoking Cessation in Patients With Squamous Cell Head and Neck Cancer Undergoing Radiation Therapy With or Without Chemotherapy | terminated | Early Phase 1 | 9 | Wake Forest University Health SciencesOTHER | 1 | Mar 22, 2023 | clinicaltrials |
| NCT05746780 | Bilateral Elective Neck Dissection in Salvage Total Laryngectomy | completed | — | 80 | Fondazione Policlinico Universitario Agostino Gemelli IRCCSOTHER | 1 | Feb 28, 2023 | clinicaltrials |
| NCT05568641 | Vitamin-D Receptor in Laryngeal Squamous Cell Carcinoma | unknown | — | 50 | Sohag UniversityOTHER | 0 | Jan 18, 2023 | clinicaltrials |
| NCT05679856 | Vocal Cord vs Whole Laryngeal Radiotherapy for T1aN0 Glottic Cancer(VC-Larynx) | unknown | N/A | 50 | National Cancer Institute, EgyptOTHER | 1 | Jan 11, 2023 | clinicaltrials |
| NCT03032250 | Prepare to Care, A Supported Self-Management Intervention for Head and Neck Cancer CaregiversHead and Neck Cancer | completed | N/A | 35 | Wake Forest University Health SciencesOTHER | 1 | Jan 9, 2023 | clinicaltrials |
| NCT05512767 | A Pneumatic Compression Device for the Treatment of Lymphedema in Patients With Stage II-IV Head and Neck Cancer After Chemoradiation | withdrawn | N/A | 0 | Mayo ClinicOTHER | 0 | Jan 6, 2023 | clinicaltrials |
| NCT04650919 | Aortic Laryngeal Rehabilitation Graft(GRAAL) | unknown | N/A | 4 | University Hospital, Strasbourg, FranceOTHER | 1 | Dec 13, 2022 | clinicaltrials |
| NCT05611515 | Treatment of Early Supraglottic Squamous Cell Carcinoma With Advance Technologies(SUPRA-QoL) | recruiting | — | 108 | Centre Hospitalier Universitaire UCLouvain NamurOTHER | 1 | Nov 10, 2022 | clinicaltrials |
| NCT04831450 | Phase 2 Trial of Maintenance Cemiplimab for Head and Neck Squamous Cell Carcinoma (HNSCC) | withdrawn | Phase 2 | 0 | University of MiamiOTHER | 0 | Aug 4, 2022 | clinicaltrials |
| NCT00470496 | Photodynamic Therapy Using HPPH in Treating Patients Undergoing Surgery for Primary or Recurrent Head and Neck Cancer | completed | Phase 1 | 15 | Roswell Park Cancer InstituteOTHER | 1 | Jul 25, 2022 | clinicaltrials |
| NCT01984502 | CyberKnife Accelerated Hemilarynx Stereotactic Radiotherapy Study for Early-stage Glottic Larynx Cancer | completed | Phase 1 | 30 | University of Texas Southwestern Medical CenterOTHER | 1 | Jun 30, 2022 | clinicaltrials |
| NCT05420597 | Induction Chemotherapy and Toripalimab Followed by Radiotherapy in Unresectable Laryngeal/Hypopharyngeal Carcinoma | unknown | Phase 2 | 61 | Fudan UniversityOTHER | 1 | Jun 15, 2022 | clinicaltrials |
| NCT02775812 | Cisplatin, Intensity-Modulated Radiation Therapy, and Pembrolizumab in Treating Patients With Stage III-IV Head and Neck Squamous Cell Carcinoma | completed | Phase 1 | 37 | National Cancer Institute (NCI)NIH | 1 | Jun 10, 2022 | clinicaltrials |
| NCT01884259 | Induction Chemotherapy With TP+5-FU or TP+Cetuximab Followed by Radioimmuptherapy for Locally Advanced or Not Resectable SCCHNN(HNO-2) | completed | Phase 2 | 100 | Arbeitsgemeinschaft medikamentoese TumortherapieOTHER | 1 | May 26, 2022 | clinicaltrials |
| NCT05293327 | IMP3 and PCNA Expression in Laryngeal Squamous Cell Carcinoma in Sohag Governorate(IMP3PCNA) | unknown | — | 70 | Sohag UniversityOTHER | 1 | Apr 1, 2022 | clinicaltrials |
| NCT04995120 | Induction Chemotherapy and Toripalimab for Larynx Preservation in Resectable Laryngeal/Hypopharyngeal Carcinoma(INSIGHT) | unknown | Phase 2 | 42 | Fudan UniversityOTHER | 1 | Jan 18, 2022 | clinicaltrials |
| NCT03096808 | Adaptive Radiotherapy for Head and Neck Cancer | completed | Phase 2 | 64 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Oct 26, 2021 | clinicaltrials |
| NCT01816984 | PI3K Inhibitor BKM120 and Cetuximab in Treating Patients With Recurrent or Metastatic Head and Neck Cancer | completed | Phase 1 / Phase 2 | 12 | University of ChicagoOTHER | 1 | Oct 5, 2021 | clinicaltrials |
| NCT03942380 | Cell-free Tumor DNA in Head and Neck Cancer Patients | unknown | N/A | 500 | Christian von BuchwaldOTHER | 1 | Sep 21, 2021 | clinicaltrials |
| NCT02430675 | Irreversible Electroporation(IRE) For Unresectable Laryngeal Neoplasms(IRE) | completed | N/A | 30 | Fuda Cancer Hospital, GuangzhouOTHER | 1 | Sep 5, 2021 | clinicaltrials |
| NCT01084733 | Nicotine Levels With Response Rates to Radiation Alone or With Chemo In Head & Neck Cancer | completed | — | 115 | Mahesh KudrimotiOTHER | 1 | Jul 14, 2021 | clinicaltrials |
| NCT01045057 | Clinical Feasibility of New Tracheoesophageal Puncture Set | completed | N/A | 27 | Atos Medical ABINDUSTRY | 4 | Jun 11, 2021 | clinicaltrials |
| NCT02177838 | Cetuximab and Radiation Therapy in Treating Patients With Stage III-IV Head and Neck Cancer | terminated | N/A | 8 | Rutgers, The State University of New JerseyOTHER | 1 | Apr 21, 2021 | clinicaltrials |
| NCT02633540 | Investigation of Contralateral Arytenoid Sparing IMRT for T1a & T2a Larynx Cancer & Analysis of Post-treatment Laryngeal Function | terminated | Phase 2 | 2 | Fox Chase Cancer CenterOTHER | 1 | Mar 9, 2021 | clinicaltrials |
| NCT00084682 | Depsipeptide in Unresectable Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck | completed | Phase 2 | 14 | National Cancer Institute (NCI)NIH | 1 | Mar 5, 2021 | clinicaltrials |
| NCT04778306 | Transoral Laser Surgery and Radiotheraphy for Early Stage Laryngeal Squamous Cell Cancer | completed | N/A | 261 | Saglik Bilimleri UniversitesiOTHER | 0 | Mar 3, 2021 | clinicaltrials |
| NCT03896958 | The PIONEER Initiative: Precision Insights On N-of-1 Ex Vivo Effectiveness Research Based on Individual Tumor Ownership (Precision Oncology)(PIONEER) | unknown | — | 1,000 | SpeciCareINDUSTRY | 1 | Dec 4, 2020 | clinicaltrials |
| NCT03292341 | Evaluation of a Web-based Decision Aid Tool for Larynx Cancer (T3/T4) Patients.(LaDecA) | completed | N/A | 9 | Maastricht Radiation OncologyOTHER | 1 | Nov 30, 2020 | clinicaltrials |
| NCT00011492 | Patient Evaluation for Head and Neck Surgery Branch Studies | terminated | — | 62 | National Institute on Deafness and Other Communication Disorders (NIDCD)NIH | 1 | Nov 27, 2020 | clinicaltrials |
| NCT03479463 | Use of Human Dehydrated Amnion Chorion Allograft in Laryngectomy/Pharyngectomy | terminated | — | 8 | MiMedx Group, Inc.INDUSTRY | 1 | Nov 13, 2020 | clinicaltrials |
| NCT04278638 | IORT in Local Advanced Laryngocarcinoma(ILAL) | unknown | N/A | 120 | Tianjin First Central HospitalOTHER | 1 | Oct 23, 2020 | clinicaltrials |
| NCT02739958 | Effects of Propofol-dexmedetomidine on Immune Function in Patients With Cancer Larynx | completed | N/A | 40 | Mansoura UniversityOTHER | 1 | Sep 22, 2020 | clinicaltrials |
| NCT04525066 | Phonosurgical Augmentation After Laser Resection of Early Glottic Carcinoma | completed | Phase 2 | 39 | Ayhman Al AfifOTHER | 0 | Aug 25, 2020 | clinicaltrials |
| NCT02464137 | HYpofractionateD RadioAblative (HYDRA) Treatment of Advanced Laryngeal Cancer(HYDRA) | terminated | Phase 1 | 15 | University of Texas Southwestern Medical CenterOTHER | 1 | Aug 20, 2020 | clinicaltrials |
| NCT01314755 | A Trial of Perioperative Immune Enhancing Feed in Patients Undergoing Surgery for Head and Neck Cancer(IMPACTHN) | completed | N/A | 76 | Terrence JonesOTHER_GOV | 1 | Aug 7, 2020 | clinicaltrials |
| NCT01249443 | Paclitaxel and Carboplatin in Treating Patients With Metastatic or Recurrent Solid Tumors and HIV Infection | terminated | Phase 1 | 17 | AIDS Malignancy ConsortiumNETWORK | 1 | Jul 29, 2020 | clinicaltrials |
| NCT03134976 | Wound Complications in Head and Neck Surgery | completed | — | 51 | University of MichiganOTHER | 1 | Jun 1, 2020 | clinicaltrials |
| NCT01192815 | Erlotinib Hydrochloride and Radiation Therapy in Stage III-IV Squamous Cell Cancer of the Head and Neck | terminated | Phase 2 | 2 | Case Comprehensive Cancer CenterOTHER | 1 | May 12, 2020 | clinicaltrials |
| NCT02236936 | Parenteral Nutrition for Patients Treated for Locally Advanced Inoperable Tumors of the Head and Neck(AGMT_HNO_PN) | terminated | Phase 3 | 8 | Arbeitsgemeinschaft medikamentoese TumortherapieOTHER | 1 | May 1, 2020 | clinicaltrials |
| NCT03132727 | Interest of MRI in Preoperative Staging for the Laryngeal and Hypopharyngeal Cancer(Larynx MRI) | completed | — | 73 | Hospices Civils de LyonOTHER | 1 | Apr 3, 2020 | clinicaltrials |
| NCT01044433 | Capecitabine and Lapatinib Ditosylate in Treating Patients With Squamous Cell Cancer of the Head and Neck | completed | Phase 2 | 44 | Abramson Cancer Center at Penn MedicineOTHER | 1 | Mar 19, 2020 | clinicaltrials |
| NCT01254617 | Lenalidomide and Cetuximab in Treating Patients With Advanced Colorectal Cancer or Head and Neck Cancer(ADCC) | completed | Phase 1 | 24 | National Cancer Institute (NCI)NIH | 1 | Mar 13, 2020 | clinicaltrials |
Data updated 23 days agoSource updated May 17, 2023source: clinicaltrials